Advertisement
Home Tags Depression

Tag: Depression

During 2013 to 2016

During 2013 to 2016, 8.1 Percent of U.S. Adults Had Depression

Depression more common in women; lower among non-Hispanic Asians than other ethnic groups
Evidence for the effectiveness of cranial electrical stimulation is sparse

Limited Evidence for Effect of Cranial Electrical Stimulation

No significant benefit for patients with fibromyalgia, pain; conflicting results for painful conditions
Acne is associated with increased probability of developing major depressive disorder

Acne Linked to Increased Risk of Major Depressive Disorder

Significantly increased risk of developing MDD in first five years after diagnosis; highest risk in first year
Telephone-administered interpersonal psychotherapy is associated with longer-term depression relief than usual care in depressed rural people living with HIV

Depressed Rural HIV Patients May Benefit From Therapy Via Phone

Telephone-administered interpersonal psychotherapy associated with fewer depressive symptoms
Persistent and severe maternal postnatal depression is associated with increased likelihood of multiple adverse child outcomes

Postnatal Depression Tied to Child Behavioral Problems

Persistent and severe PND linked to risk of behavior problems at 3.5 years, lower math grades at 16
For adolescents with depression who declined or quickly stopped using antidepressants

Cognitive Behavioral Therapy Cost-Effective in Depressed Teens

CBT associated with lower costs in adolescents who declined or quit taking antidepressants
Transdermal estradiol plus intermittent micronized progesterone can prevent clinically significant depressive symptoms among euthymic perimenopausal and early postmenopausal women

Transdermal Estradiol May Help Prevent Depressive Symptoms

Effects of TE, micronized progesterone seen in perimenopausal, early postmenopausal women
For patients with type 1 diabetes

Bidirectional Association for Depression, Dysglycemia in T1DM

Depression increases risk of dysglycemia especially in first six months to one year of diagnosis
Transcranial direct current stimulation appears to be effective and safe as an add-on intervention for adults with bipolar depression

Transcranial Direct Current Stimulation Promising for Bipolar

tDCS seems effective and safe for adults with bipolar depression receiving stable pharmacologic regimen
Esketamine seems to be efficacious and safe for patients with treatment-resistant depression

Esketamine Safe, Effective for Treatment-Resistant Depression

Change in Montgomery-Åsberg Depression Rating Scale score superior for esketamine versus placebo